Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥55.69 Million ≈ $8.15 Million USD) by net assets (CN¥1.33 Billion ≈ $194.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Cheng Yi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Zhejiang Cheng Yi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Cheng Yi Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Cheng Yi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Qinghai Huzhu Barley Wine Co Ltd SHE:002646	0.000x
Baolingbao Biology Co Ltd SHE:002286	0.061x
Bannerman Energy Ltd AU:BMN	-0.008x
Cheng Uei Precision Industry Co Ltd TW:2392	0.217x
Peoples Fin NASDAQ:PFIS	0.029x
Guangdong TianYiMa Information Industry Co.Ltd. SHE:301178	N/A
Xinhua Winshare Publishing and Media Co. Ltd F:SXV	0.026x
Northern Data AG XETRA:NB2	-0.021x

Annual Cash Flow Conversion Efficiency for Zhejiang Cheng Yi Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Cheng Yi Pharmaceutical Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.27 Billion ≈ $185.12 Million	CN¥205.72 Million ≈ $30.10 Million	0.163x	-0.10%
2023-12-31	CN¥1.20 Billion ≈ $175.10 Million	CN¥194.78 Million ≈ $28.50 Million	0.163x	+7.02%
2022-12-31	CN¥1.09 Billion ≈ $159.64 Million	CN¥165.94 Million ≈ $24.28 Million	0.152x	+5.89%
2021-12-31	CN¥998.88 Million ≈ $146.17 Million	CN¥143.49 Million ≈ $21.00 Million	0.144x	-28.41%
2020-12-31	CN¥886.09 Million ≈ $129.66 Million	CN¥177.81 Million ≈ $26.02 Million	0.201x	-14.76%
2019-12-31	CN¥768.96 Million ≈ $112.52 Million	CN¥181.01 Million ≈ $26.49 Million	0.235x	+18.06%
2018-12-31	CN¥673.54 Million ≈ $98.56 Million	CN¥134.30 Million ≈ $19.65 Million	0.199x	+79.10%
2017-12-31	CN¥599.57 Million ≈ $87.74 Million	CN¥66.75 Million ≈ $9.77 Million	0.111x	-67.19%
2016-12-31	CN¥280.17 Million ≈ $41.00 Million	CN¥95.08 Million ≈ $13.91 Million	0.339x	+7.65%
2015-12-31	CN¥259.92 Million ≈ $38.03 Million	CN¥81.94 Million ≈ $11.99 Million	0.315x	-7.44%
2014-12-31	CN¥246.95 Million ≈ $36.14 Million	CN¥84.11 Million ≈ $12.31 Million	0.341x	+42.35%
2013-12-31	CN¥201.40 Million ≈ $29.47 Million	CN¥48.19 Million ≈ $7.05 Million	0.239x	+12.28%
2012-12-31	CN¥178.13 Million ≈ $26.07 Million	CN¥37.96 Million ≈ $5.55 Million	0.213x	+117.73%
2011-12-31	CN¥102.60 Million ≈ $15.01 Million	CN¥10.04 Million ≈ $1.47 Million	0.098x	--

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

SHG:603811 China Drug Manufacturers - Specialty & Generic

Market Cap

$568.51 Million

CN¥3.89 Billion CNY

Market Cap Rank

#11900 Global

#3656 in China

Share Price

CN¥11.87

Change (1 day)

+0.08%

52-Week Range

CN¥8.80 - CN¥16.82

All Time High

CN¥19.93